Notably, PTX treatment reduced the tumor sizes of S18 cells significantly but not S18 OE cells, indicating that enhanced NOTCH3 activation and signaling confers chemoresistance of NPC in vivo (Fig. 6A–C, Supplementary Fig. S5A–B). This evidence concerns the gene NOTCH3 and neoplasm.